Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Albina Nowak

Showing results (21-30 of 105) with videos related to

Pageof 11
Sort By:
Molecular Genetics and Metabolism|July 1, 2017
Correlation of Lyso-Gb3 levels in dried blood spots and sera from patients with classic and Later-Onset Fabry diseaseAlbina Nowak, Thomas Mechtler, David C Kasper, et al.
Molecular Genetics and Metabolism|September 10, 2022
Agalsidase-β should be proposed as first line therapy in classic male Fabry patients with undetectable α-galactosidase A activityAlbina Nowak, Olivier Dormond, Véronique Monzambani, et al.
Scientific Reports|November 17, 2021
Detection of single nucleotide and copy number variants in the Fabry disease-associated GLA gene using nanopore sequencingAlbina Nowak, Omer Murik, Tzvia Mann, et al.
Orphanet Journal of Rare Diseases|June 28, 2022
COVID-19 in Fabry disease: a reference center prospective studyChristina Bothou, Lanja Saleh, Arnold von Eckardstein, et al.
Journal of Medical Genetics|January 26, 2021
Lyso-Gb3 associates with adverse long-term outcome in patients with Fabry diseaseAlbina Nowak, Felix Beuschlein, Visnuka Sivasubramaniam, et al.
Molecular Genetics and Metabolism|October 25, 2016
Plasma LysoGb3: A useful biomarker for the diagnosis and treatment of Fabry disease heterozygotesAlbina Nowak, Thomas P Mechtler, Robert J Desnick, et al.
Biomedicines|August 29, 2024
Dynamics of Leukocyte Telomere Length in Patients with Fabry DiseaseTina Levstek, Nika Breznik, Bojan Vujkovac, et al.
Frontiers in Psychiatry|April 4, 2022
Neuropsychiatric Symptoms and Their Association With Sex, Age, and Enzyme Replacement Therapy in Fabry Disease: A Systematic ReviewMagdalena Mroczek, Ignazio Maniscalco, Manon Sendel, et al.
Therapeutische Umschau. Revue Therapeutique|November 24, 2018
[Wilson's disease or hepatolenticular degeneration]Bernd Mensing, Albina Nowak, Sandrine Zweifel, et al.
Biochimica Et Biophysica Acta. Molecular Basis of Disease|July 19, 2019
Global glycosphingolipid analysis in urine and plasma of female Fabry disease patientsWendy E Heywood, Ivan Doykov, Justyna Spiewak, et al.
Pageof 11

Showing results (21-30 of 105) with videos related to

Sort By:
Pageof 11
Molecular Genetics and Metabolism|July 1, 2017
Correlation of Lyso-Gb3 levels in dried blood spots and sera from patients with classic and Later-Onset Fabry diseaseAlbina Nowak, Thomas Mechtler, David C Kasper, et al.
Molecular Genetics and Metabolism|September 10, 2022
Agalsidase-β should be proposed as first line therapy in classic male Fabry patients with undetectable α-galactosidase A activityAlbina Nowak, Olivier Dormond, Véronique Monzambani, et al.
Scientific Reports|November 17, 2021
Detection of single nucleotide and copy number variants in the Fabry disease-associated GLA gene using nanopore sequencingAlbina Nowak, Omer Murik, Tzvia Mann, et al.
Orphanet Journal of Rare Diseases|June 28, 2022
COVID-19 in Fabry disease: a reference center prospective studyChristina Bothou, Lanja Saleh, Arnold von Eckardstein, et al.
Journal of Medical Genetics|January 26, 2021
Lyso-Gb3 associates with adverse long-term outcome in patients with Fabry diseaseAlbina Nowak, Felix Beuschlein, Visnuka Sivasubramaniam, et al.
Molecular Genetics and Metabolism|October 25, 2016
Plasma LysoGb3: A useful biomarker for the diagnosis and treatment of Fabry disease heterozygotesAlbina Nowak, Thomas P Mechtler, Robert J Desnick, et al.
Biomedicines|August 29, 2024
Dynamics of Leukocyte Telomere Length in Patients with Fabry DiseaseTina Levstek, Nika Breznik, Bojan Vujkovac, et al.
Frontiers in Psychiatry|April 4, 2022
Neuropsychiatric Symptoms and Their Association With Sex, Age, and Enzyme Replacement Therapy in Fabry Disease: A Systematic ReviewMagdalena Mroczek, Ignazio Maniscalco, Manon Sendel, et al.
Therapeutische Umschau. Revue Therapeutique|November 24, 2018
[Wilson's disease or hepatolenticular degeneration]Bernd Mensing, Albina Nowak, Sandrine Zweifel, et al.
Biochimica Et Biophysica Acta. Molecular Basis of Disease|July 19, 2019
Global glycosphingolipid analysis in urine and plasma of female Fabry disease patientsWendy E Heywood, Ivan Doykov, Justyna Spiewak, et al.
Pageof 11